GSK sells rabies and tick vaccines to rival in $1.1bn deal

Sale comes as pharma giant shifts its focus to cancer drug market

London-listed pharmaceutical giant GlaxoSmithKline (GSK) will sell two travel vaccines to Bavarian Nordic for around $1.1bn (£821m, €955m) in an effort to shift the company’s focus to the cancer drug market.

This comes in the wake of a $5.1bn acquisition of US cancer drugmaker Tesaro in January.

Bavarian Nordic, the Danish biotechnology firm, will purchase the Encepur and Rabipur (used to stop tick-borne encephalitis) from GSK with an upfront payment of €301m and milestone payments exceeding €495m.

Roger Connor, president of Global Vaccines at GSK, stated: “This agreement with Bavarian Nordic will enable us to commit greater resources to our key growth assets and to our R&D pipeline.”

What is your sentiment on GSK?

43.85
Bullish
or
Bearish
Vote to see community's results!

CEO Emma Walmsley has spearheaded the shift towards the cancer drug market since assuming the role in 2017. She is also overseeing the upcoming separation of GSK’s consumer-facing products and drugs businesses into separate entities.

The drugmaker last year reported total revenue of £30.82bn. Its share price is down on the month but up on the year to date, standing at around £1,628.53 in mid-morning trading.

GlaxoSmithKline plc
Daily change
43.66
Low: 42.91
High: 43.68
The material provided on this website is for information purposes only and should not be regarded as investment research or investment advice. Any opinion that may be provided on this page is a subjective point of view of the author and does not constitute a recommendation by Currency Com Bel LLC or its partners. We do not make any endorsements or warranty on the accuracy or completeness of the information that is provided on this page. By relying on the information on this page, you acknowledge that you are acting knowingly and independently and that you accept all the risks involved.
iPhone Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat
iMac Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat
iMac Image